L. Lundorff, MD, P. Sjøgren, DmSci, MD, O. B. Hansen, MD, T. Jonsson, MD, P. R. Nielsen, and L. Christrup, PhD, MSc(Pharm), “Switching from high doses of pure µ-opioid agonists to transdermal buprenorphine in patients with cancer: A feasibility study”, J of Opioid Management, vol. 9, no. 4, pp. 255–262, Jul. 2013.